Children with medulloblastomas show diverse clinical courses even when receiving similar treatments. In this study, comparative genomic hybridization, which allows the detection of losses and gains in DNA copy number along the entire genome, was used to investigate the genetic alterations in 6 cases of medulloblastoma with adequate follow-up periods and similar treatments, and in a medulloblastoma cell line. In the cell line, the number of aberrations was the highest of all samples examined. In 6 clinical samples, frequently altered regions (more than 3 cases) observed in all medulloblastomas were gains of 7q and 17q (4 cases each), and of 2p, 2q and 7p (3 cases each). High-grade amplification was observed at the loci 8q, 17q and 21q, each in a single case. The case with the most favorable outcome 9 years after surgery had the smallest number of chromosomal changes among the cases examined. Our results may indicate that further acquisition of genetic alterations detected by comparative genomic hybridization are associated with unfavorable prognosis in patients with medulloblastomas.

Keywords:
Comparative genomic hybridization, Medulloblastomas, Genetic alterations
1.
Biegel JA, Rorke LB, Packer RJ, Sutton LN, Schut L, Bonner K, Emanuel BS: Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer 1989;1:139–147.
2.
Bigner SH, Mark J, Friedman HS, Biegel JA, Bigner DD: Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 1988;30:91–101.
3.
Callen DF, Cirocco L, Moore L: A der(11)t(8;11) in two medulloblastomas. A possible nonrandom cytogenetic abnormality. Cancer Genet Cytogenet 1989;38:255–260.
4.
Griffin CA, Hawkins AL, Packer RJ, Rorke LB, Emanuel BS: Chromosome abnormalities in pediatric brain tumors. Cancer Res 1988;48:175–180.
5.
Karnes PS, Tran TN, Cui MY, Raffel C, Gilles FH, Barranger JA, Ying KL: Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet Cytogenet 1992;59:12–19.
6.
Bigner SH, Vogelstein B: Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol 1990;1:12–18.
7.
Kraus JA, Koch A, Albrecht S, von Deimling A, Wiestler OD, Pietsch T: Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma. Int J Cancer 1996;67:11–15.
8.
Bigner SH, Mark J, Bigner DD: Cytogenetics of human brain tumors. Cancer Genet Cytogenet 1990;47:141–154.
9.
Arnoldus EP, Wolters LB, Voormolen JH, van Duinen SG, Raap AK, van der Ploeg M, Peters AC: Interphase cytogenetics: A new tool for the study of genetic changes in brain tumors. J Neurosurg 1992;76:997–1003.
10.
Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818–821.
11.
Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 1994;91:2156–2160.
12.
Nishizaki T, Ozaki S, Harada K, Ito H, Arai K, Beppu T, Sasaki K: Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosomes Cancer 1998;21:340–346.
13.
Isola J, DeVries S, Chu L, Ghazvini S, Waldman F: Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994;145:1301–1308.
14.
Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, Waldman FM: Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997;74:513–517.
15.
Nishizaki T, DeVries S, Chew K, Goodson WH III, Ljung BM, Thor A, Waldman FM: Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 1997;19:267–272.
16.
Bayani J, Thorner P, Zielenska M, Pandita A, Beatty B, Squire JA: Application of simplified comparative genomic hybridization technique to screen for gene amplification in pediatric solid tumors. Pediatr Pathol Lab Med 1995;15:831–844.
17.
Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST, Valentine MB, Behm FG, Li H, Heideman RL, Kun LE, Shapiro DN, Look T: Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 1997;57:4042–4047.
18.
Kleiheus P, Burger PC, Scheithauer BW: The new classification of brain tumors. Brain Pathol 1993;3:255–268.
19.
Kokunai T, Tamaki N, Matsumoto S: Differentiation of a medulloblastoma cell line mediated by protein kinase A; in Tabuchi K (ed): Biological Aspect of Brain Tumors. Tokyo, Springer, 1991, pp 436–441.
20.
Tatsumi S, Kokunai T, Tamaki N: Production and characterization of a monoclonal antibody against medulloblastoma-derived cell line. Neurol Med Chir (Tokyo) 1996;36:277–285.
21.
Cogen PH, Daneshvar L, Metzger AK, Duyk G, Edwards MS, Sheffield VC: Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet 1992;50:584–589.
22.
Cogen PH, Daneshvar L, Metzger AK, Edwards MS: Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics 1990;8:279–285.
23.
Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P: p53 mutations in nonastrocytic human brain tumors. Cancer Res 1991;51:6202–6205.
24.
Raffel C, Gilles FE, Weinberg KI: Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood. Cancer Res 1990;50:587–591.
25.
Wasson JC, Saylors RL III, Zeltzer P, Friedman HS, Bigner SH, Burger PC, Bigner DD, Look AT, Douglass EC, Brodeur GM: Oncogene amplification in pediatric brain tumors. Cancer Res 1990;50:2987–2990.
26.
Scheurlen WG, Krauss J, Kuhl J: No preferential loss of one parental allele of chromosome 17p13.3 in childhood medulloblastoma. Int J Cancer 1995;63:372–374.
27.
Biegel JA, Burk CD, Barr FG, Emanuel BS: Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 1992;52:3391–3395.
28.
Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG: Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 1997;150:81–89.
29.
Iijima M, Nakazato Y: Pale islands in medulloblastoma consist of differentiated cells with low growth potential. Pathol Int 1997;47:25–30.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.